ID   LEF_BACAN               Reviewed;         809 AA.
AC   P15917; Q8KYJ6; Q933F6;
DT   01-APR-1990, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 2.
DT   22-JUL-2015, entry version 147.
DE   RecName: Full=Lethal factor;
DE            Short=LF;
DE            EC=3.4.24.83;
DE   AltName: Full=Anthrax lethal toxin endopeptidase component;
DE   Flags: Precursor;
GN   Name=lef; OrderedLocusNames=pXO1-107, BXA0172, GBAA_pXO1_0172;
OS   Bacillus anthracis.
OG   Plasmid pXO1.
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Bacillus;
OC   Bacillus cereus group.
OX   NCBI_TaxID=1392;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND PROTEIN SEQUENCE OF 34-49.
RX   PubMed=2509294; DOI=10.1016/0378-1119(89)90335-1;
RA   Bragg T.S., Robertson D.L.;
RT   "Nucleotide sequence and analysis of the lethal factor gene (lef) from
RT   Bacillus anthracis.";
RL   Gene 81:45-54(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Lowe J.;
RT   "A comparison of Bacillus anthracis sequences.";
RL   Submitted (APR-1990) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Sterne;
RX   PubMed=10515943;
RA   Okinaka R.T., Cloud K., Hampton O., Hoffmaster A.R., Hill K.K.,
RA   Keim P., Koehler T.M., Lamke G., Kumano S., Mahillon J., Manter D.,
RA   Martinez Y., Ricke D., Svensson R., Jackson P.J.;
RT   "Sequence and organization of pXO1, the large Bacillus anthracis
RT   plasmid harboring the anthrax toxin genes.";
RL   J. Bacteriol. 181:6509-6515(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=Ames / isolate Florida / A2012;
RX   PubMed=12004073; DOI=10.1126/science.1071837;
RA   Read T.D., Salzberg S.L., Pop M., Shumway M.F., Umayam L., Jiang L.,
RA   Holtzapple E., Busch J.D., Smith K.L., Schupp J.M., Solomon D.,
RA   Keim P., Fraser C.M.;
RT   "Comparative genome sequencing for discovery of novel polymorphisms in
RT   Bacillus anthracis.";
RL   Science 296:2028-2033(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=Ames ancestor;
RX   PubMed=18952800; DOI=10.1128/JB.01347-08;
RA   Ravel J., Jiang L., Stanley S.T., Wilson M.R., Decker R.S., Read T.D.,
RA   Worsham P., Keim P.S., Salzberg S.L., Fraser-Liggett C.M., Rasko D.A.;
RT   "The complete genome sequence of Bacillus anthracis Ames 'Ancestor'.";
RL   J. Bacteriol. 191:445-446(2009).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-809.
RC   STRAIN=Carbosap, and Ferrara;
RX   PubMed=12067380; DOI=10.1046/j.1365-2672.2002.01660.x;
RA   Adone R., Pasquali P., La Rosa G., Marianelli C., Muscillo M.,
RA   Fasanella A., Francia M., Ciuchini F.;
RT   "Sequence analysis of the genes encoding for the major virulence
RT   factors of Bacillus anthracis vaccine strain 'Carbosap'.";
RL   J. Appl. Microbiol. 93:117-121(2002).
RN   [7]
RP   FUNCTION.
RX   PubMed=9563949; DOI=10.1126/science.280.5364.734;
RA   Duesbery N.S., Webb C.P., Leppla S.H., Gordon V.M., Klimpel K.R.,
RA   Copeland T.D., Ahn N.G., Oskarsson M.K., Fukasawa K., Paull K.D.,
RA   Vande Woude G.F.;
RT   "Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal
RT   factor.";
RL   Science 280:734-737(1998).
RN   [8]
RP   FUNCTION.
RX   PubMed=9703991; DOI=10.1006/bbrc.1998.9040;
RA   Vitale G., Pellizzari R., Recchi C., Napolitani G., Mock M.,
RA   Montecucco C.;
RT   "Anthrax lethal factor cleaves the N-terminus of MAPKKs and induces
RT   tyrosine/threonine phosphorylation of MAPKs in cultured macrophages.";
RL   Biochem. Biophys. Res. Commun. 248:706-711(1998).
RN   [9]
RP   FUNCTION.
RX   PubMed=10475971; DOI=10.1046/j.1365-2672.1999.00892.x;
RA   Duesbery N.S., Vande Woude G.F.;
RT   "Anthrax lethal factor causes proteolytic inactivation of mitogen-
RT   activated protein kinase kinase.";
RL   J. Appl. Microbiol. 87:289-293(1999).
RN   [10]
RP   FUNCTION.
RX   PubMed=11104681; DOI=10.1042/0264-6021:3520739;
RA   Vitale G., Bernardi L., Napolitani G., Mock M., Montecucco C.;
RT   "Susceptibility of mitogen-activated protein kinase kinase family
RT   members to proteolysis by anthrax lethal factor.";
RL   Biochem. J. 352:739-745(2000).
RN   [11]
RP   FUNCTION.
RX   PubMed=10338520;
RA   Tang G., Leppla S.H.;
RT   "Proteasome activity is required for anthrax lethal toxin to kill
RT   macrophages.";
RL   Infect. Immun. 67:3055-3060(1999).
RN   [12]
RP   CHARACTERIZATION.
RX   PubMed=8942659; DOI=10.1021/bi961518b;
RA   Wang X.-M., Mock M., Ruysschaert J.-M., Cabiaux V.;
RT   "Secondary structure of anthrax lethal toxin proteins and their
RT   interaction with large unilamellar vesicles: a Fourier-transform
RT   infrared spectroscopy approach.";
RL   Biochemistry 35:14939-14946(1996).
RN   [13]
RP   ZINC-BINDING.
RX   PubMed=7851740; DOI=10.1111/j.1574-6968.1994.tb07306.x;
RA   Kochi S.K., Schiavo G., Mock M., Montecucco C.;
RT   "Zinc content of the Bacillus anthracis lethal factor.";
RL   FEMS Microbiol. Lett. 124:343-348(1994).
RN   [14]
RP   REGULATION OF TOXIN EXPRESSION.
RC   STRAIN=Sterne;
RX   PubMed=8051039;
RA   Sirard J.-C., Mock M., Fouet A.;
RT   "The three Bacillus anthracis toxin genes are coordinately regulated
RT   by bicarbonate and temperature.";
RL   J. Bacteriol. 176:5188-5192(1994).
RN   [15]
RP   MUTAGENESIS OF HIS-719; GLU-720 AND HIS-723.
RC   STRAIN=Sterne;
RX   PubMed=9573135;
RA   Hammond S.E., Hanna P.C.;
RT   "Lethal factor active-site mutations affect catalytic activity in
RT   vitro.";
RL   Infect. Immun. 66:2374-2378(1998).
RN   [16]
RP   MUTAGENESIS OF VAL-180; TYR-181; TYR-182; GLU-183; ILE-184; GLY-185
RP   AND LYS-186.
RC   STRAIN=Sterne;
RX   PubMed=11162493; DOI=10.1006/bbrc.2000.4099;
RA   Gupta P., Singh A., Chauhan V., Bhatnagar R.;
RT   "Involvement of residues 147VYYEIGK153 in binding of lethal factor to
RT   protective antigen of Bacillus anthracis.";
RL   Biochem. Biophys. Res. Commun. 280:158-163(2001).
RN   [17]
RP   MUTAGENESIS OF ASP-220; LEU-221; LEU-222 AND PHE-223.
RC   STRAIN=Sterne;
RX   PubMed=12113932; DOI=10.1111/j.1574-6968.2002.tb11264.x;
RA   Singh A., Chauhan V., Sodhi A., Bhatnagar R.;
RT   "Asp 187 and Phe 190 residues in lethal factor are required for the
RT   expression of anthrax lethal toxin activity.";
RL   FEMS Microbiol. Lett. 212:183-186(2002).
RN   [18]
RP   REVIEW.
RX   PubMed=11595637; DOI=10.1016/S0041-0101(01)00161-1;
RA   Brossier F., Mock M.;
RT   "Toxins of Bacillus anthracis.";
RL   Toxicon 39:1747-1755(2001).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) IN COMPLEX WITH ZINC IONS AND
RP   MAP2K2.
RX   PubMed=11700563; DOI=10.1038/n35101998;
RA   Pannifer A.D., Wong T.Y., Schwarzenbacher R., Renatus M., Petosa C.,
RA   Bienkowska J., Lacy D.B., Collier R.J., Park S., Leppla S.H.,
RA   Hanna P.C., Liddington R.C.;
RT   "Crystal structure of the anthrax lethal factor.";
RL   Nature 414:229-233(2001).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (3.52 ANGSTROMS) OF 34-809 IN COMPLEX WITH ZINC
RP   IONS AND PEPTIDE SUBSTRATE ANALOG.
RX   PubMed=14718924; DOI=10.1038/nsmb708;
RA   Turk B.E., Wong T.Y., Schwarzenbacher R., Jarrell E.T., Leppla S.H.,
RA   Collier R.J., Liddington R.C., Cantley L.C.;
RT   "The structural basis for substrate and inhibitor selectivity of the
RT   anthrax lethal factor.";
RL   Nat. Struct. Mol. Biol. 11:60-66(2004).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 297-809 IN COMPLEX WITH ZINC
RP   IONS AND PROTEASE INHIBITOR.
RX   PubMed=15911756; DOI=10.1073/pnas.0502159102;
RA   Shoop W.L., Xiong Y., Wiltsie J., Woods A., Guo J., Pivnichny J.V.,
RA   Felcetto T., Michael B.F., Bansal A., Cummings R.T., Cunningham B.R.,
RA   Friedlander A.M., Douglas C.M., Patel S.B., Wisniewski D., Scapin G.,
RA   Salowe S.P., Zaller D.M., Chapman K.T., Scolnick E.M., Schmatz D.M.,
RA   Bartizal K., MacCoss M., Hermes J.D.;
RT   "Anthrax lethal factor inhibition.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:7958-7963(2005).
CC   -!- FUNCTION: One of the three proteins composing the anthrax toxin,
CC       the agent which infects many mammalian species and that may cause
CC       death. LF is the lethal factor that, when associated with PA,
CC       causes death. LF is not toxic by itself. It is a protease that
CC       cleaves the N-terminal of most dual specificity mitogen-activated
CC       protein kinase kinases (MAPKKs or MAP2Ks) (except for MAP2K5).
CC       Cleavage invariably occurs within the N-terminal proline-rich
CC       region preceding the kinase domain, thus disrupting a sequence
CC       involved in directing specific protein-protein interactions
CC       necessary for the assembly of signaling complexes. There may be
CC       other cytosolic targets of LF involved in cytotoxicity. The
CC       proteasome may mediate a toxic process initiated by LF in the cell
CC       cytosol involving degradation of unidentified molecules that are
CC       essential for macrophage homeostasis. This is an early step in
CC       LeTx intoxication, but it is downstream of the cleavage by LF of
CC       MEK1 or other putative substrates. {ECO:0000269|PubMed:10338520,
CC       ECO:0000269|PubMed:10475971, ECO:0000269|PubMed:11104681,
CC       ECO:0000269|PubMed:9563949, ECO:0000269|PubMed:9703991}.
CC   -!- CATALYTIC ACTIVITY: Preferred amino acids around the cleavage site
CC       can be denoted BBBBxHx-|-H, in which B denotes Arg or Lys, H
CC       denotes a hydrophobic amino acid, and x is any amino acid. The
CC       only known protein substrates are mitogen-activated protein (MAP)
CC       kinase kinases.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion per subunit.;
CC   -!- SUBUNIT: Anthrax toxins are composed of three distinct proteins, a
CC       protective antigen (PA), a lethal factor (LF) and an edema factor
CC       (EF). None of these is toxic by itself. PA+LF forms the lethal
CC       toxin (LeTx); PA+EF forms the edema toxin (EdTx).
CC       {ECO:0000269|PubMed:11700563, ECO:0000269|PubMed:14718924,
CC       ECO:0000269|PubMed:15911756}.
CC   -!- INTERACTION:
CC       P13423:pagA; NbExp=5; IntAct=EBI-456923, EBI-456868;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- INDUCTION: Positively transcriptionally regulated by AtxA, which,
CC       in turn, is induced by bicarbonate and high temperatures (37
CC       degrees Celsius).
CC   -!- DOMAIN: It comprises four domains: domain I binds the membrane-
CC       translocating component (PA); domains II, III and IV together
CC       create a long deep groove that holds the 16-residue N-terminal
CC       tail of MAPKK before cleavage. Domain IV contains the catalytic
CC       center.
CC   -!- DOMAIN: The PA-binding region is found in both B.anthracis EF and
CC       LF.
CC   -!- MISCELLANEOUS: LF binds to the heptamer formed by cleaved PA on
CC       the host cell membrane. This step is followed by internalization
CC       of the hetero-oligomeric complex by receptor-mediated endocytosis.
CC       LeTx requires passage through an acidic vesicle for activity; at
CC       acidic pH, as the pore is inserted into the membrane, LF is
CC       translocated and reaches its cytosolic targets. LF is probably
CC       directly involved in its routing, by interacting with the lipid
CC       membrane. This interaction could involve a conformational change
CC       of LF and/or an oligomerization of the protein. LF may have the
CC       capability of partially unfolding in order to cross the membrane.
CC   -!- SIMILARITY: Belongs to the peptidase M34 family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M29081; AAA79216.1; -; Genomic_DNA.
DR   EMBL; M30210; AAA22569.1; -; Genomic_DNA.
DR   EMBL; AF065404; AAD32411.1; -; Genomic_DNA.
DR   EMBL; AE011190; AAM26117.1; -; Genomic_DNA.
DR   EMBL; AE017336; AAT28913.2; -; Genomic_DNA.
DR   EMBL; AJ413934; CAC93932.1; -; Genomic_DNA.
DR   EMBL; AJ413935; CAC93933.1; -; Genomic_DNA.
DR   PIR; JQ0032; JQ0032.
DR   RefSeq; NP_052803.1; NC_001496.1.
DR   RefSeq; WP_001022097.1; NZ_KN050652.1.
DR   RefSeq; WP_010890024.1; NZ_JHCB02000028.1.
DR   PDB; 1J7N; X-ray; 2.30 A; A/B=34-809.
DR   PDB; 1JKY; X-ray; 3.90 A; A=34-809.
DR   PDB; 1PWP; X-ray; 2.90 A; A/B=34-809.
DR   PDB; 1PWQ; X-ray; 3.52 A; A/B=34-809.
DR   PDB; 1PWU; X-ray; 2.70 A; A/B=34-809.
DR   PDB; 1PWV; X-ray; 2.85 A; A/B=34-809.
DR   PDB; 1PWW; X-ray; 2.80 A; A/B=34-809.
DR   PDB; 1YQY; X-ray; 2.30 A; A=297-809.
DR   PDB; 1ZXV; X-ray; 2.67 A; A/B=34-809.
DR   PDB; 2L0R; NMR; -; A=705-809.
DR   PDB; 3KWV; X-ray; 3.10 A; C/F=34-296.
DR   PDB; 4DV8; X-ray; 1.63 A; A=296-809.
DR   PDB; 4PKQ; X-ray; 2.20 A; A=298-809.
DR   PDB; 4PKR; X-ray; 2.20 A; A=298-809.
DR   PDB; 4PKS; X-ray; 2.30 A; A=298-809.
DR   PDB; 4PKT; X-ray; 2.40 A; A=298-809.
DR   PDB; 4PKU; X-ray; 2.40 A; A=298-809.
DR   PDB; 4PKV; X-ray; 2.50 A; A=298-809.
DR   PDB; 4PKW; X-ray; 1.75 A; A=298-809.
DR   PDBsum; 1J7N; -.
DR   PDBsum; 1JKY; -.
DR   PDBsum; 1PWP; -.
DR   PDBsum; 1PWQ; -.
DR   PDBsum; 1PWU; -.
DR   PDBsum; 1PWV; -.
DR   PDBsum; 1PWW; -.
DR   PDBsum; 1YQY; -.
DR   PDBsum; 1ZXV; -.
DR   PDBsum; 2L0R; -.
DR   PDBsum; 3KWV; -.
DR   PDBsum; 4DV8; -.
DR   PDBsum; 4PKQ; -.
DR   PDBsum; 4PKR; -.
DR   PDBsum; 4PKS; -.
DR   PDBsum; 4PKT; -.
DR   PDBsum; 4PKU; -.
DR   PDBsum; 4PKV; -.
DR   PDBsum; 4PKW; -.
DR   ProteinModelPortal; P15917; -.
DR   SMR; P15917; 62-809.
DR   DIP; DIP-29871N; -.
DR   IntAct; P15917; 1.
DR   MINT; MINT-7014731; -.
DR   BindingDB; P15917; -.
DR   ChEMBL; CHEMBL3301396; -.
DR   MEROPS; M34.001; -.
DR   EnsemblBacteria; AAT28913; AAT28913; GBAA_pXO1_0172.
DR   GeneID; 3361711; -.
DR   KEGG; bar:GBAA_pXO1_0172; -.
DR   KEGG; pg:3361711; -.
DR   PATRIC; 24662141; VBIBacAnt106580_0160.
DR   eggNOG; NOG45846; -.
DR   HOGENOM; HOG000034565; -.
DR   KO; K08645; -.
DR   OMA; RMMARYE; -.
DR   OrthoDB; EOG62ZHV6; -.
DR   BioCyc; ANTHRA:GBAA_PXO1_0172-MONOMER; -.
DR   BioCyc; BANT261594:GJ7F-5757-MONOMER; -.
DR   BRENDA; 3.4.24.83; 634.
DR   Reactome; REACT_264618; Uptake and function of anthrax toxins.
DR   EvolutionaryTrace; P15917; -.
DR   PRO; PR:P15917; -.
DR   Proteomes; UP000000594; Plasmid pXO1.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; TAS:Reactome.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008237; F:metallopeptidase activity; EXP:Reactome.
DR   GO; GO:0009405; P:pathogenesis; IEP:CACAO.
DR   GO; GO:0006508; P:proteolysis; IDA:CACAO.
DR   Gene3D; 1.10.2030.10; -; 1.
DR   Gene3D; 3.40.390.10; -; 2.
DR   InterPro; IPR015239; Anthrax_tox_lethal-fac_cen.
DR   InterPro; IPR003541; Anthrax_toxin_lethal/edema.
DR   InterPro; IPR014781; Anthrax_toxin_lethal/edema_N/C.
DR   InterPro; IPR024079; MetalloPept_cat_dom.
DR   Pfam; PF09156; Anthrax-tox_M; 1.
DR   Pfam; PF07737; ATLF; 2.
DR   PRINTS; PR01392; ANTHRAXTOXNA.
DR   PROSITE; PS00142; ZINC_PROTEASE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing; Hydrolase;
KW   Metal-binding; Metalloprotease; Plasmid; Protease; Reference proteome;
KW   Repeat; Secreted; Signal; Toxin; Virulence; Zinc.
FT   SIGNAL        1     33       {ECO:0000269|PubMed:2509294}.
FT   CHAIN        34    809       Lethal factor.
FT                                /FTId=PRO_0000029233.
FT   REPEAT      315    333       1.
FT   REPEAT      342    357       2.
FT   REPEAT      360    378       3.
FT   REPEAT      380    397       4.
FT   REPEAT      399    416       5.
FT   REGION       34    293       PA-binding region. {ECO:0000255}.
FT   REGION       60    295       I; PA-binding region. {ECO:0000255}.
FT   REGION      296    330       IIA.
FT   REGION      315    416       5 X approximate repeats.
FT   REGION      336    416       III.
FT   REGION      420    583       IIB.
FT   REGION      585    809       IV.
FT   ACT_SITE    720    720
FT   METAL       719    719       Zinc; catalytic.
FT   METAL       723    723       Zinc; catalytic.
FT   METAL       768    768       Zinc; catalytic.
FT   VARIANT     299    299       A -> S (in strain: Sterne).
FT   MUTAGEN     180    180       V->A: No effect on PA-binding ability.
FT                                {ECO:0000269|PubMed:11162493}.
FT   MUTAGEN     181    181       Y->A: Loss of ability to bind to PA.
FT                                {ECO:0000269|PubMed:11162493}.
FT   MUTAGEN     182    182       Y->A: Loss of ability to bind to PA.
FT                                {ECO:0000269|PubMed:11162493}.
FT   MUTAGEN     183    183       E->A: No effect on PA-binding ability.
FT                                {ECO:0000269|PubMed:11162493}.
FT   MUTAGEN     184    184       I->A: Loss of ability to bind to PA.
FT                                {ECO:0000269|PubMed:11162493}.
FT   MUTAGEN     185    185       G->A: No effect on PA-binding ability.
FT                                {ECO:0000269|PubMed:11162493}.
FT   MUTAGEN     186    186       K->A: Loss of ability to bind to PA.
FT                                {ECO:0000269|PubMed:11162493}.
FT   MUTAGEN     220    220       D->A: Loss of ability to bind to PA and
FT                                loss of toxicity.
FT                                {ECO:0000269|PubMed:12113932}.
FT   MUTAGEN     221    221       L->A: No effect on PA-binding ability and
FT                                fully toxic.
FT                                {ECO:0000269|PubMed:12113932}.
FT   MUTAGEN     222    222       L->A: No effect on PA-binding ability and
FT                                fully toxic.
FT                                {ECO:0000269|PubMed:12113932}.
FT   MUTAGEN     223    223       F->A: Loss of ability to bind to PA and
FT                                non-toxic. {ECO:0000269|PubMed:12113932}.
FT   MUTAGEN     719    719       H->A: Loss of activity and zinc binding.
FT                                {ECO:0000269|PubMed:9573135}.
FT   MUTAGEN     720    720       E->C,D: Loss of activity. No effect on
FT                                zinc binding.
FT                                {ECO:0000269|PubMed:9573135}.
FT   MUTAGEN     723    723       H->A: Loss of activity and zinc binding.
FT                                {ECO:0000269|PubMed:9573135}.
FT   TURN         62     65       {ECO:0000244|PDB:1J7N}.
FT   HELIX        66     76       {ECO:0000244|PDB:1J7N}.
FT   STRAND       77     80       {ECO:0000244|PDB:1J7N}.
FT   HELIX        87     97       {ECO:0000244|PDB:1J7N}.
FT   HELIX       101    109       {ECO:0000244|PDB:1J7N}.
FT   STRAND      113    119       {ECO:0000244|PDB:1J7N}.
FT   HELIX       121    123       {ECO:0000244|PDB:1J7N}.
FT   HELIX       125    127       {ECO:0000244|PDB:1J7N}.
FT   HELIX       132    135       {ECO:0000244|PDB:1J7N}.
FT   STRAND      136    138       {ECO:0000244|PDB:1J7N}.
FT   STRAND      144    146       {ECO:0000244|PDB:1J7N}.
FT   HELIX       147    149       {ECO:0000244|PDB:1J7N}.
FT   STRAND      151    155       {ECO:0000244|PDB:1J7N}.
FT   STRAND      157    159       {ECO:0000244|PDB:1J7N}.
FT   STRAND      161    165       {ECO:0000244|PDB:1J7N}.
FT   TURN        170    172       {ECO:0000244|PDB:1J7N}.
FT   HELIX       174    190       {ECO:0000244|PDB:1J7N}.
FT   HELIX       193    196       {ECO:0000244|PDB:1J7N}.
FT   HELIX       201    211       {ECO:0000244|PDB:1J7N}.
FT   STRAND      213    216       {ECO:0000244|PDB:1J7N}.
FT   HELIX       217    222       {ECO:0000244|PDB:1J7N}.
FT   HELIX       225    228       {ECO:0000244|PDB:1J7N}.
FT   HELIX       236    240       {ECO:0000244|PDB:1J7N}.
FT   HELIX       243    258       {ECO:0000244|PDB:1J7N}.
FT   HELIX       260    269       {ECO:0000244|PDB:1J7N}.
FT   HELIX       271    282       {ECO:0000244|PDB:1J7N}.
FT   HELIX       284    293       {ECO:0000244|PDB:1J7N}.
FT   HELIX       300    310       {ECO:0000244|PDB:4DV8}.
FT   HELIX       312    317       {ECO:0000244|PDB:4DV8}.
FT   HELIX       320    330       {ECO:0000244|PDB:4DV8}.
FT   HELIX       337    342       {ECO:0000244|PDB:4DV8}.
FT   HELIX       346    354       {ECO:0000244|PDB:4DV8}.
FT   HELIX       357    359       {ECO:0000244|PDB:4DV8}.
FT   STRAND      361    363       {ECO:0000244|PDB:4PKW}.
FT   HELIX       365    379       {ECO:0000244|PDB:4DV8}.
FT   STRAND      381    383       {ECO:0000244|PDB:4PKR}.
FT   HELIX       384    389       {ECO:0000244|PDB:4DV8}.
FT   STRAND      392    394       {ECO:0000244|PDB:1YQY}.
FT   HELIX       403    412       {ECO:0000244|PDB:4DV8}.
FT   HELIX       413    415       {ECO:0000244|PDB:4DV8}.
FT   HELIX       421    428       {ECO:0000244|PDB:4DV8}.
FT   STRAND      435    437       {ECO:0000244|PDB:4DV8}.
FT   HELIX       439    455       {ECO:0000244|PDB:4DV8}.
FT   STRAND      458    460       {ECO:0000244|PDB:1PWV}.
FT   HELIX       461    464       {ECO:0000244|PDB:4DV8}.
FT   TURN        465    467       {ECO:0000244|PDB:4DV8}.
FT   STRAND      470    474       {ECO:0000244|PDB:4DV8}.
FT   HELIX       476    478       {ECO:0000244|PDB:4DV8}.
FT   HELIX       481    484       {ECO:0000244|PDB:4DV8}.
FT   TURN        485    487       {ECO:0000244|PDB:4PKT}.
FT   HELIX       498    505       {ECO:0000244|PDB:4DV8}.
FT   STRAND      510    515       {ECO:0000244|PDB:4DV8}.
FT   STRAND      518    522       {ECO:0000244|PDB:4DV8}.
FT   STRAND      532    537       {ECO:0000244|PDB:4DV8}.
FT   STRAND      543    547       {ECO:0000244|PDB:4DV8}.
FT   TURN        548    550       {ECO:0000244|PDB:4DV8}.
FT   STRAND      551    554       {ECO:0000244|PDB:4DV8}.
FT   STRAND      556    570       {ECO:0000244|PDB:4DV8}.
FT   STRAND      573    583       {ECO:0000244|PDB:4DV8}.
FT   HELIX       585    607       {ECO:0000244|PDB:4DV8}.
FT   STRAND      616    619       {ECO:0000244|PDB:4DV8}.
FT   HELIX       625    642       {ECO:0000244|PDB:4DV8}.
FT   HELIX       645    657       {ECO:0000244|PDB:4DV8}.
FT   STRAND      662    667       {ECO:0000244|PDB:4DV8}.
FT   HELIX       669    671       {ECO:0000244|PDB:4DV8}.
FT   HELIX       673    676       {ECO:0000244|PDB:4DV8}.
FT   HELIX       682    684       {ECO:0000244|PDB:4DV8}.
FT   STRAND      688    693       {ECO:0000244|PDB:4DV8}.
FT   HELIX       694    696       {ECO:0000244|PDB:4DV8}.
FT   STRAND      698    705       {ECO:0000244|PDB:4DV8}.
FT   TURN        709    711       {ECO:0000244|PDB:2L0R}.
FT   HELIX       713    733       {ECO:0000244|PDB:4DV8}.
FT   STRAND      735    737       {ECO:0000244|PDB:4DV8}.
FT   HELIX       741    743       {ECO:0000244|PDB:4DV8}.
FT   HELIX       745    754       {ECO:0000244|PDB:4DV8}.
FT   TURN        755    757       {ECO:0000244|PDB:4PKV}.
FT   HELIX       761    763       {ECO:0000244|PDB:4DV8}.
FT   HELIX       766    777       {ECO:0000244|PDB:4DV8}.
FT   HELIX       782    791       {ECO:0000244|PDB:4DV8}.
FT   HELIX       793    807       {ECO:0000244|PDB:4DV8}.
SQ   SEQUENCE   809 AA;  93770 MW;  2076B4D7277317EE CRC64;
     MNIKKEFIKV ISMSCLVTAI TLSGPVFIPL VQGAGGHGDV GMHVKEKEKN KDENKRKDEE
     RNKTQEEHLK EIMKHIVKIE VKGEEAVKKE AAEKLLEKVP SDVLEMYKAI GGKIYIVDGD
     ITKHISLEAL SEDKKKIKDI YGKDALLHEH YVYAKEGYEP VLVIQSSEDY VENTEKALNV
     YYEIGKILSR DILSKINQPY QKFLDVLNTI KNASDSDGQD LLFTNQLKEH PTDFSVEFLE
     QNSNEVQEVF AKAFAYYIEP QHRDVLQLYA PEAFNYMDKF NEQEINLSLE ELKDQRMLAR
     YEKWEKIKQH YQHWSDSLSE EGRGLLKKLQ IPIEPKKDDI IHSLSQEEKE LLKRIQIDSS
     DFLSTEEKEF LKKLQIDIRD SLSEEEKELL NRIQVDSSNP LSEKEKEFLK KLKLDIQPYD
     INQRLQDTGG LIDSPSINLD VRKQYKRDIQ NIDALLHQSI GSTLYNKIYL YENMNINNLT
     ATLGADLVDS TDNTKINRGI FNEFKKNFKY SISSNYMIVD INERPALDNE RLKWRIQLSP
     DTRAGYLENG KLILQRNIGL EIKDVQIIKQ SEKEYIRIDA KVVPKSKIDT KIQEAQLNIN
     QEWNKALGLP KYTKLITFNV HNRYASNIVE SAYLILNEWK NNIQSDLIKK VTNYLVDGNG
     RFVFTDITLP NIAEQYTHQD EIYEQVHSKG LYVPESRSIL LHGPSKGVEL RNDSEGFIHE
     FGHAVDDYAG YLLDKNQSDL VTNSKKFIDI FKEEGSNLTS YGRTNEAEFF AEAFRLMHST
     DHAERLKVQK NAPKTFQFIN DQIKFIINS
//
